Syndax Pharmaceuticals (SNDX) PT Lowered to $37 at UBS
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $19.84 +3.98%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS analyst David Dai lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $37.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Syndax Pharmaceuticals (SNDX) PT Lowered to $40 at JPMorgan
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
